
ABOUT SAMSUNG BIOLOGICS
Samsung Biologics is a full-service provider offering development and cGMP manufacturing services. We deliver a broad range of services from development and manufacturing to fill and finish, covering both clinical molecules and commercial products. Established in April 2011, Samsung Biologics will transform the global healthcare industry over the next decade through our quality, technology and innovation. Our facilities are custom designed for monoclonal & recombinant production with maximum flexibility. Our one-stop services include cell line generation, process and analytical method development, analytical services (characterization, comparability, IPC, lot release & stability), and clinical and commercial bulk cGMP manufacturing of drug substance and drug product. We also provide quality assurance and quality control services, as well as worldwide regulatory compliance standards & support for our customers. We are centrally located in the heart of Asia, within 20 minutes of Incheon International Airport.
CONTACT INFORMATION
Samsung Biologics
300 Songdo Bio Way, Yeonsu-gu
Incheon, 21987
KOREA, REPUBLIC OF
Phone: +82 32 455 3114
Contact: Jinyong Kim
BROCHURES
FEATURED ARTICLES
- Mitigating Risks Associated With Single-Use Systems: Critical Considerations
- Best Practices For Biopharmaceutical Technology Transfer: Facility Fit And Process Gap Assessments
- Choose A CDMO Partner That Integrates Market Intelligence For Aseptic Fill And Finish
- What You Should Know About Cell Line Development To Ensure A Successful Launch
- Embracing Necessary Digital Transformation In Biomanufacturing
- Beyond COVID-19: How Localization Strengthens Supply Chains
- Key Considerations To Ensure A Successful Drug Substance Transfer
- How The Integration Of CDMO And CRO Services Benefits Everyone
- The Challenges Of Biopharmaceutical Quality
- It Depends: The Real Answer To The Single-Use Or Stainless-Steel Question
WEBINARS
-
Considerations When Outsourcing Aseptic Fill/ Finish To A CMO
This presentation addresses keys to outsourced drug production, including the importance of seeking the right partnerships to help overcome the challenges associated with secure commercial product supply.
-
Get To IND Faster
This webinar presents a 3-month cell line development timeline for a high quality cell line with outstanding productivity to support your molecule's successful development path to IND.
-
Biopharmaceutical Process Characterization
Here we present process development and characterization strategies required to support commercial scale manufacture of antibody therapeutics.
VIDEOS
-
S-CHOice Cell Line Expression Technology
Samsung Biologics proudly presents the official launch of their proprietary cell line, S-CHOice, a high-performing technology to start your successful therapeutics development journey. We can now offer our clients even more promising options in bringing their molecule faster and better to the market with world-class client satisfaction.
-
Building A Better Future
Samsung Biologics’ vision is to enrich human life with technology and innovation. By continuously innovating our people, process, and portfolio, we will fulfill our mission to become the most trusted partner to our clients working together to achieve "Better Life" for humanity through biomedicines.